Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 170,531 | 200,290 | 102,208 | 131,289 | 168,836 |
| Receivables | 4,962 | 4,293 | 4,541 | 3,351 | 1,283 |
| Inventories | 42,198 | 41,881 | 36,705 | 34,031 | 27,242 |
| Other current assets | 2,519 | 2,830 | 4,289 | 2,769 | 3,388 |
| TOTAL | $220,210 | $249,294 | $147,743 | $171,440 | $200,749 |
| Non-Current Assets | |||||
| PPE Net | 5,014 | 5,083 | 2,604 | 1,412 | 1,455 |
| Intangibles | 3,208 | 3,208 | 3,208 | 3,208 | 3,208 |
| Other Non-Current Assets | 1,100 | 1,100 | 1,099 | 1,099 | 307 |
| TOTAL | $9,322 | $9,391 | $6,911 | $5,719 | $4,970 |
| Total Assets | $229,532 | $258,685 | $154,654 | $177,159 | $205,719 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,748 | 26,795 | 23,935 | 21,504 | 33,069 |
| Accrued Expenses | 3,580 | N/A | 4,439 | 4,060 | 2,573 |
| Other current liabilities | 49,030 | 47,285 | 244 | 244 | N/A |
| TOTAL | $70,076 | $77,606 | $30,603 | $27,337 | $36,356 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,718 | 3,526 | 1,985 | 1,529 | 714 |
| Other Non-Current Liabilities | 109,251 | 93,355 | 2,214 | 1,938 | 99 |
| TOTAL | $110,061 | $94,145 | $2,981 | $2,683 | $821 |
| Total Liabilities | $180,137 | $171,751 | $33,584 | $30,020 | $37,177 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,821 | 105,876 | 105,193 | 105,172 | 103,596 |
| Common Shares | 106 | 105 | 105 | 105 | 104 |
| Retained earnings | -714,967 | -674,003 | -636,219 | -605,474 | -578,597 |
| Other shareholders' equity | -357 | -357 | -357 | -357 | -357 |
| TOTAL | $49,395 | $86,934 | $121,070 | $147,139 | $168,542 |
| Total Liabilities And Equity | $229,532 | $258,685 | $154,654 | $177,159 | $205,719 |